Close
Update on clinical trials – part 1

Update on clinical trials – part 1

Reading Time: 5 minutes This is blog number 19 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond to the code in the abstract book. Click on the number to be redirected to the full abstract (the page may take a minute to load). Clinical trials are research…

Virtual Symposium: Update on AMX0035 CENTAUR and open-label extension trials

Virtual Symposium: Update on AMX0035 CENTAUR and open-label extension trials

Reading Time: 5 minutes This blog is part of the ‘Virtual Highlights’ collection of articles, where you can read about the content of some of the talks and posters presented at the Virtual 31st International Symposium on ALS/MND. This presentation was part of Session 3: Clinical Trials. Presented by Dr Sabrina Paganoni, from the Sean M. Healey & AMG…

Update on the CENTAUR trial: open label extension data

Update on the CENTAUR trial: open label extension data

Reading Time: 3 minutes A centaur was a creature from Greek mythology which was half-man and half-horse. Despite such an unusual appearance such a combination could have its advantages. It seems that another combination may hold promise in the future for people with ALS/MND (see our previous blog). The CENTAUR clinical trial, which tested a combination of two compounds,…